POLATUZUMAB-VEDOTIN+BENDAMUSTIN+RITUXIMAB AS SALVAGE AND BRIDGING THERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Although diffuse large B-cell lymphoma (DLBCL) represents a paradigm of highly curative disease with a complete remission (CR) rate of ≈ 60%–70% in an upfront setting, the remaining 30%–40% of patients present a relapse/refractory setting. These population are highly critical and amended for salvage treatment approach. Novel appro...
By Ivan Petković, Marija Elez, Aleksandar Popović, Slavica Stojnev, Irena Conic, Miljana Džunić, Dane Krtinić
Perimandibular metastasis of rectal cancer: A case report
Introduction. Colorectal cancer is the third most common cancer and metastatic disease is an important and frequent clinical problem. Metastases in the oral and maxillofacial region are rare, comprising 1-2% of all malignant lesions, and clinically resemble common benign conditions. Case report. A 59-year-old woman diagnosed with rectal cancer deve...
By Miljana Džunić, Ana Cvetanović, Ivan Petković
Prognostic parameters in patients with resected liver metastases from colorectal cancer after biological and chemotherapy
The aim of the research was to investigate prognostic factors in patients with resected colorectal liver metastases (CLMs) after biological and chemotherapy, which made initially unresectable disease suitable for resection. Sixty-six patients with resected CLMs, operated after induction bio-chemotherapy with bevacizumab + FOLFOX4, treated at the Cl...
By Miljana Džunić, Ivan Petković, Ana Cvetanović, Ivica Pejčić, Svetislav Vrbić, Saša Dinić
Nodal and extranodal peripheral T/NK-cell neoplasms: Current aspects
...
By Ivan Petković, Aleksandar Popović, Miljana Džunić, Ivica Pejčić